Skip to main content
EDEN RESEARCH PLC logo

EDEN RESEARCH PLC — Investor Relations & Filings

Ticker · EDEN ISIN · GB0001646941 LEI · 213800ZWTYTVQQSM3J85 IL Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2018-05-10 Director's Dealing
Country GB United Kingdom
Listing IL EDEN

About EDEN RESEARCH PLC

https://www.edenresearch.com/

Eden Research plc develops and supplies sustainable biopesticides and plastic-free encapsulation technologies. The company's core innovation is its proprietary Sustaine® microencapsulation system, which protects and delivers naturally occurring, plant-based active ingredients known as terpenes. Its products serve three primary markets: crop protection, animal health, and consumer products. The crop protection portfolio includes the biofungicide Mevalone® and the bionematicide Cedroz®, designed for applications such as foliar disease control, soil pest management, and post-harvest treatments. In animal health and consumer goods, its technologies are used in products like shampoos, flea and tick control, deodorants, and head-lice treatments.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is identified by the 'RNS Number' header and contains details about a transaction involving shares by a person discharging managerial responsibilities (Mr. Alex Abrey, CFO). Specifically, it details the 'Sale of shares' by a Director/PDMR. This type of insider transaction reporting aligns directly with the definition of Director's Dealing (DIRS). Although it uses the RNS distribution system, the specific content dictates the DIRS classification over the general RNS fallback.
2018-05-10 English
Exercise of Options
Director's Dealing Classification · 99% confidence The document is an official announcement filed via RNS (RNS Number : 2991N) dated May 8, 2018. The content explicitly details the 'Exercise of Options' by the Chief Financial Officer (a Person Discharging Managerial Responsibilities - PDMR) and provides the resulting change in his shareholding and the total voting rights. This type of filing, reporting personal share transactions by directors/executives, directly corresponds to the definition of 'Director's Dealing' (DIRS). Although it is an RNS announcement, the specific nature of the content (insider trade/PDMR dealing) makes DIRS the most precise classification over the general RNS fallback.
2018-05-08 English
Preliminary results
Earnings Release Classification · 100% confidence The document explicitly states it announces the 'preliminary results for the year ended 31 December 2017' and provides detailed 'Financial highlights' and 'Business highlights' for that period. This content structure (financial summary, operational review, management commentary) is characteristic of an Earnings Release (ER) or an Interim/Annual Report. Since the document covers the full year (ended 31 December 2017) and contains detailed financial figures, it is a comprehensive annual result announcement. However, it is presented as an RNS announcement (RNS Number : 2181I) and is relatively brief compared to a full 10-K filing, focusing on key highlights and management commentary. This format strongly suggests it is the initial, formal announcement of the annual results, which aligns best with the Earnings Release (ER) definition, even though it covers a full year. If it were the full statutory filing, it would be a 10-K. Given the context of an RNS announcement detailing preliminary results, ER is the most appropriate classification over the comprehensive 10-K. FY 2017
2018-03-20 English
Year-end Trading Statement
Regulatory Filings Classification · 98% confidence The document is explicitly labeled with "RNS Number : 5494B" and concludes with "This information is provided by RNS The company news service from the London Stock Exchange". The content is a "Year-end trading update" providing preliminary financial figures (£1.9m revenue, £0.9m loss) for the year ended 31 December 2017, along with operational highlights (regulatory approvals, patent growth, commercial agreements). This is a typical announcement of preliminary results or a trading update, which is generally classified as an Earnings Release (ER) if it contains key financial highlights, or a Regulatory Filing (RNS) if it's a general announcement. Since it provides specific, albeit preliminary, financial performance metrics for a period, ER is a strong candidate. However, the presence of the RNS identifier and the nature of the announcement (a trading update rather than a formal, detailed earnings release) suggests it fits well within the general regulatory announcement category, RNS, which serves as a fallback for specific announcements not covered elsewhere. Given the options, ER (Earnings Release) is for initial announcements of key highlights, and this document provides those highlights and operational context. Since it is a formal announcement via the RNS system detailing performance metrics, ER is the most specific fit for preliminary results, although RNS is also applicable. I will choose ER as it focuses on the financial performance update.
2018-01-11 English
Regulatory Progress Update
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is dated 12 December 2017. The title is 'Regulatory progress update'. The content discusses a distribution partner (Eastman) submitting regulatory dossiers for a new product (CedrozTM) in Israel, Europe, and Mexico. This is a specific operational update concerning regulatory progress and partnership activities, rather than a full financial report (10-K, IR, ER) or a general announcement of a report being published (RPA). Since it is a specific, material update released via the RNS system that doesn't fit the other specific categories (like DIRS, DIV, MANG, etc.), it falls best under the general regulatory announcement category, RNS, which serves as a fallback for specific operational news released through regulatory channels.
2017-12-12 English
Half-year Report - Replacement
Interim / Quarterly Report Classification · 100% confidence The document is a 'Half Yearly Report' for Eden Research plc for the six months ended 30 June 2017. It contains comprehensive financial statements (Statement of Comprehensive Income), management commentary, and operational highlights. It is not a mere announcement of a report, as it provides the full interim financial data. Therefore, it is classified as an Interim / Quarterly Report. H1 2017
2017-09-29 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.